Company Profile - Accelerate Diagnostics Inc

Introduction

Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company engaged in the development and commercialization of instruments for the identification and testing of antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, a platform for the identification (ID) and antibiotic susceptibility testing (AST) of infectious pathogens; and Accelerate PhenoTest BC kit, which provides ID and AST results for patients with bacteremia or fungemia. It operates a manufacturing facility in Tucson, Arizona. The company sells products directly and also through a network of third-party distributors to hospital microbiology laboratories in domestic and foreign countries. Accelerate is headquartered in Tucson, Arizona, the US.

Company info

Country (HQ): United States
Sector: Medical Equipment
Market Cap (US$ m): 75
Revenue (US$ m): 13 (2022)

Innovation ranking

407

Innovation score

Closest peers in the Medical Equipment sector

Innovation Ranking

Company
Headquarters
Sector

Medtronic Plc

Ireland

Medical Equipment

Boston Scientific Corp

United States

Medical Equipment

Accelerate Diagnostics Inc

United States

Medical Equipment

Savara Inc

United States

Medical Equipment

Aethlon Medical Inc

United States

Medical Equipment

Are you ranked? Get the Innovation Ranking Report

  • Company Ranking Report
    • If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
    • Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
    • Contextualised information on the company's standing in relation to peers
    • Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
    • Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
  • Rosettes
  • Certificate of Achievement
  • Press release
Screenshot of Deal Makers